niacinamide and ceritinib

niacinamide has been researched along with ceritinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dolgikh, N; Fulda, S	1

Other Studies

1 other study(ies) available for niacinamide and ceritinib

Article	Year
Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase status. Anti-cancer drugs, 2017, Volume: 28, Issue:10 Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Drug Synergism; Humans; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; Rhabdomyosarcoma; Sorafenib; Sulfones	2017

Article

Year

Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase status.

Anti-cancer drugs, 2017, Volume: 28, Issue:10

Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Drug Synergism; Humans; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; Rhabdomyosarcoma; Sorafenib; Sulfones

2017